OneTouch Ultra Shipment Stoppage Unlikely To Impact J&J/LifeScan Sales
This article was originally published in The Gray Sheet
Executive SummaryJohnson & Johnson/LifeScan's decision to temporarily cease shipments of its OneTouch Ultra, OneTouch FastTake and InDuo blood glucose meters likely will not significantly affect the unit's revenue, the firm said
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.